Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeff Sharman
Tumour Debulking and Reduction in Predicted Risk of Tumour Lysis Syndrome With Single-Agent Ibrutinib in Patients With Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology
An Open-Label, Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.
Postgraduate Medical Journal
Medicine
Venetoclax‐induced Tumour Lysis Syndrome in Acute Myeloid Leukaemia
British Journal of Haematology
Hematology
Acute Respiratory Distress Syndrome Associated With Tumour Lysis Syndrome in Leukemia
Canadian Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Single Dose Rasburicase Is a Clinically Effective Pharmacoeconomic Approach for Preventing Tumour Lysis Syndrome in Children With High Tumour Burden
British Journal of Haematology
Hematology
An Assessment of a Short-Term Tumour Chemosensitivity Assay in Chronic Lymphocytic Leukaemia
British Journal of Cancer
Cancer Research
Oncology
Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Lack of Adequate Pneumococcal Vaccination Response in Chronic Lymphocytic Leukaemia Patients Receiving Ibrutinib
British Journal of Haematology
Hematology
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autoimmune Cytopenias in Patients With Chronic Lymphocytic Leukaemia Treated With Ibrutinib in Routine Clinical Practice at an Academic Medical Centre
British Journal of Haematology
Hematology
